GlassScriptPhysician profile
Roderick K King
NPI 1982823035
$2,052.30
in general payments reported to CMS, 2019-2025
9 companies · $591 in 2025
The $591 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,461 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,017 · Education: $35.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,016.67 |
| Education | $35.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $531.98 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Abbott Laboratories | $371.01 | 2024-2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $279.98 | 2024 | Evoke |
| Biotronik Nro, INC. | $241.80 | 2024-2025 | Prospera |
| Painteq LLC | $153.12 | 2024 | Painteq |
| Syndax Pharmaceuticals, INC. | $148.77 | 2025 | Revuforj |
| Nevro Corp. | $147.72 | 2024 | Senza |
| Medtronic, INC. | $145.77 | 2024 | Intellis Adaptivestim, Synchromedii |
| Abbvie INC. | $32.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roderick King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.